Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Transmedics Group Inc (TMDX)

Transmedics Group Inc (TMDX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 423,491
  • Shares Outstanding, K 21,164
  • Annual Sales, $ 13,017 K
  • Annual Income, $ -23,756 K
  • 60-Month Beta N/A
  • Price/Sales 19.44
  • Price/Cash Flow N/A
  • Price/Book 6.65

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.37
  • Number of Estimates 3
  • High Estimate -0.34
  • Low Estimate -0.41
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.04%

Price Performance

See More
Period Period Low Period High Performance
1-Month
16.74 +15.77%
on 11/12/19
20.93 -7.41%
on 12/09/19
+2.54 (+15.08%)
since 11/11/19
3-Month
15.74 +23.09%
on 11/08/19
25.47 -23.91%
on 09/12/19
-5.34 (-21.60%)
since 09/11/19

Most Recent Stories

More News
TransMedics' OCS Technology Sees Success in Heart Transplant

TransMedics (TMDX) successfully completes heart transplants from DCD donors, using its OCS technology.

HAE : 117.55 (+0.01%)
RMD : 150.48 (+1.01%)
EYE : 30.63 (+1.76%)
TMDX : 19.38 (-3.15%)
TransMedics' Organ Care System (OCS(TM)) Technology Used in First U.S. Adult Human Heart Transplants From DCD Donors

TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today announced...

TMDX : 19.38 (-3.15%)
TransMedics: 3Q Earnings Snapshot

ANDOVER, Mass. (AP) _ TransMedics Group Inc. (TMDX) on Wednesday reported a loss of $8.3 million in its third quarter.

TMDX : 19.38 (-3.15%)
TransMedics Reports Third Quarter 2019 Financial Results

TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today reported...

TMDX : 19.38 (-3.15%)
TransMedics Announces Change to Time of Third Quarter 2019 Earnings Conference Call on Wednesday, November 6

TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today announced...

TMDX : 19.38 (-3.15%)
TransMedics to Report Third Quarter 2019 Financial Results on November 6, 2019

TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today announced...

TMDX : 19.38 (-3.15%)
TransMedics to Present at the 17th Annual Morgan Stanley Global Healthcare Conference

TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today announced...

MS : 49.45 (-0.44%)
TMDX : 19.38 (-3.15%)
TransMedics Reports Second Quarter 2019 Financial Results

TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today reported...

TMDX : 19.38 (-3.15%)
Hercules Capital Reports Second Quarter 2019 Financial Results

--Achieved Record Quarter for New Debt and Equity Commitments and Total Fundings of $534.8 Million and $368.1 Million, Respectively

WFC : 53.17 (-0.97%)
PINS : 18.20 (+1.17%)
TMDX : 19.38 (-3.15%)
FSLY : 20.25 (-3.57%)
BBIO : 36.73 (-0.54%)
AQ : 13.24 (unch)
MRVL : 24.78 (+4.65%)
VICL : 0.68 (-15.68%)
HTGC : 14.24 (-0.49%)
HCXZ : 25.70 (+0.39%)
HCXY : 26.36 (+0.04%)
TransMedics Announces Successful Long Distance Retrieval and Transplantation of Donor Lungs from Hawaii Using Organ Care System (OCS(TM))

TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today announced...

TMDX : 19.38 (-3.15%)
Trade TMDX with:

Business Summary

TransMedics Inc. is a commercial-stage medical technology company. It is engaged in transforming organ transplant therapy for end-stage organ failure patients. The company offers Organ Care System, an integrated, compact, portable preservation technology which addresses unmet need for organs for transplantation....

See More

Key Turning Points

2nd Resistance Point 20.91
1st Resistance Point 20.15
Last Price 19.38
1st Support Level 18.88
2nd Support Level 18.37

See More

52-Week High 31.54
Fibonacci 61.8% 25.51
Fibonacci 50% 23.64
Fibonacci 38.2% 21.78
Last Price 19.38
52-Week Low 15.74

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar